Tag: precision psychiatry

Marianne Apostolides discusses how Go/No-Go grew from her search for new eating-disorder treatments into a critique of the metaphors, experiments, and technologies shaping contemporary neuroscience and psychiatry. She argues that efforts to reduce distress to circuits, algorithms, and biomarkers often overlook subjectivity, agency, and the human relationships that meaningful care requires.

Genetic testing to guide antidepressant selection is already being sold to the public, but the evidence is less than convincing. A new study failed to show efficacy in its primary outcome, its secondary outcomes imply a potential benefit for only 2% of patients, and it contradicts the findings of a previous study, leaving interpretation uncertain.

A letter just published in JAMA Psychiatry suggests that “precision psychiatry” is not the paradigm shift it’s purported to be by the psychiatric establishment.